Date Filer Title Filing Type Shares Traded Price Total Held
Aug 05, 2026
Principal Accounting Officer
Principal Accounting Officer Form 3 Initial Statement of Beneficial Ownership of Securities 5,000 -- --
Aug 05, 2026
General Counsel
General Counsel Form 3 Initial Statement of Beneficial Ownership of Securities 15,000 -- --
Aug 05, 2026
Chief Scientific Officer
Chief Scientific Officer Form 3 Initial Statement of Beneficial Ownership of Securities 54,000 -- --
Aug 05, 2026
Chief Operating Officer
Chief Operating Officer Form 3 Initial Statement of Beneficial Ownership of Securities 15,000 -- --
Aug 03, 2026
Principal Accounting Officer
Principal Accounting Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 5,000 -- 5,000
Aug 03, 2026
General Counsel
General Counsel Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 15,000 -- 15,000
Aug 03, 2026
Chief Scientific Officer
Chief Scientific Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 54,000 -- 54,000
Aug 03, 2026
Chief Operating Officer
Chief Operating Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 15,000 -- 15,000
Jul 30, 2026
Chief Scientific Officer
Chief Scientific Officer Form 3 Initial Statement of Beneficial Ownership of Securities -- -- 63
Jun 03, 2026
Principal Accounting Officer
Principal Accounting Officer Form 4 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 7 $1.30 253

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.